Literature DB >> 24797767

Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Mahdi Shabani1, Ali Ahmad Bayat, Mahmood Jeddi-Tehrani, Hodjatallah Rabbani, Mohammad Hojjat-Farsangi, Cristina Ulivieri, Zahra Amirghofran, Cosima Tatiana Baldari, Fazel Shokri.   

Abstract

B-cell antigen receptor (BCR) signalling and its regulation through negative and positive regulators are critical for balancing B-cell response and function. Human Fc receptor like-2 (FCRL2), a member of the newly identified FCRL family, could influence B-cell signalling due to possession of both immunoreceptor tyrosine-based activation and inhibitory motifs (ITAM and ITIM). Since the natural ligand of FCRL2 has not been identified, we generated FCRL2-specific monoclonal antibodies (mAbs) and employed them to investigate the influence of FCRL2 stimulation on BCR signalling in an FCRL2-expressing B-cell line. Two anti-FCRL2 mAb-producing hybridoma clones (5A7-E7 and 3D8-G8) were selected. None of the mAbs displayed any cross-reactivity with the other members of the FCRL family including recombinant FCRL1, -3, -4 and -5, as tested by FACS and ELISA techniques. Engagement of the FCRL2 by these mAbs resulted in significant inhibition of BCR signalling mediators such as calcium mobilization and phosphorylation of the mitogen-activated protein kinases Erk, p38 and Jnk. These findings indicate that the FCRL2 ITIM motifs are functional and the anti-FCRL2 mAbs may mimic the natural ligand of FCRL2 by induction of inhibitory signals in B cells.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  B-cell receptor signalling; Fc receptor like-2; monoclonal antibody

Mesh:

Substances:

Year:  2014        PMID: 24797767      PMCID: PMC4212948          DOI: 10.1111/imm.12311

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells.

Authors:  Y Nakayama; S M Weissman; A L Bothwell
Journal:  Biochem Biophys Res Commun       Date:  2001-07-20       Impact factor: 3.575

2.  Identification of a family of Fc receptor homologs with preferential B cell expression.

Authors:  R S Davis; Y H Wang; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

Review 3.  B cell antigen receptor signaling 101.

Authors:  Joseph M Dal Porto; Stephen B Gauld; Kevin T Merrell; David Mills; Aimee E Pugh-Bernard; John Cambier
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

4.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

5.  Characterization of novel murine monoclonal antibodies directed against the extracellular domain of human HER2 tyrosine kinase receptor.

Authors:  Tohid Kazemi; Fathollah Tahmasebi; Ali Ahmad Bayat; Neda Mohajer; Jalal Khoshnoodi; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Hybridoma (Larchmt)       Date:  2011-08

Review 6.  B cell antigen receptor signaling: roles in cell development and disease.

Authors:  Stephen B Gauld; Joseph M Dal Porto; John C Cambier
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

7.  FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells.

Authors:  Tanisha A Jackson; Christopher L Haga; Götz R A Ehrhardt; Randall S Davis; Max D Cooper
Journal:  J Immunol       Date:  2010-11-10       Impact factor: 5.422

8.  The inhibitory potential of Fc receptor homolog 4 on memory B cells.

Authors:  Gotz R A Ehrhardt; Randall S Davis; Joyce T Hsu; Chuen-Miin Leu; Annette Ehrhardt; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

9.  B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy.

Authors:  Diego Catalán; Octavio Aravena; Francisca Sabugo; Pamela Wurmann; Lilian Soto; Alexis M Kalergis; Miguel Cuchacovich; Juan C Aguillón
Journal:  Arthritis Res Ther       Date:  2010-04-15       Impact factor: 5.156

10.  Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.

Authors:  Christopher L Haga; Götz R A Ehrhardt; Rebecca J Boohaker; Randall S Davis; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

View more
  1 in total

Review 1.  Targeted Therapies in Adult B-Cell Malignancies.

Authors:  Jean-François Rossi
Journal:  Biomed Res Int       Date:  2015-09-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.